Doctors could get a head start treating cancer thanks to new AI developed at...
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their severity throughout the course of a patient’s treatment.

Machine learning model predicts cancer patients’ symptoms

In what is believed to be the first study of its kind, researchers from the Centre for Vision, Speech and Signal Processing (CVSSP) at the University of Surrey detail how they created two machine learning models that are both able to accurately predict the severity of three common symptoms faced by cancer patients – depression, anxiety and sleep disturbance. All three symptoms are associated with severe reduction in cancer patients’ quality of life.

Researchers analysed existing data of the symptoms experienced by cancer patients during the course of computed tomography x-ray treatment. The team used different time periods during this data to test whether the machine learning algorithms are able to accurately predict when and if symptoms surfaced. The results found that the actual reported symptoms were very close to those predicted by the machine learning methods.

Payam Barnaghi, Professor of Machine Intelligence at the University of Surrey, said: “These exciting results show that there is an opportunity for machine learning techniques to make a real difference in the lives of people living with cancer. They can help clinicians identify high-risk patients, help and support their symptom experience and pre-emptively plan a way to manage those symptoms and improve quality of life.”

Nikos Papachristou, who worked on designing the machine learning algorithms for this project, said: “I am very excited to see how machine learning and AI can be used to create solutions that have a positive impact on the quality of life and well-being of patients.”

Professor Adrian Hilton, Director of Surrey’s Centre for Vision, Speech and Signal Processing (CVSSP), said: “These exciting developments by Professor Barnaghi and his team show the incredible potential of machine learning in transforming the way healthcare professionals treat people suffering from cancer. We continue to explore the boundless potential of AI at CVSSP and we believe our work has a real place in helping to shape the future of health services across the globe.”

This work has been a collaboration between the University of Surrey and the University of California in San Francisco (UCSF). The UCSF research in this joint collaboration is led by Professor Christine Miaskowski.

Subscribe to our newsletter

Related articles

Deep learning identifies molecular patterns of cancer

Deep learning identifies molecular patterns of cancer

An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.

AI system predicts which cancer patients benefit from immunotherapy

AI system predicts which cancer patients benefit from immunotherapy

Using machine learning, researchers have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are likely to benefit from immunotherapy.

Using AI to predict risk of thyroid cancer on ultrasound

Using AI to predict risk of thyroid cancer on ultrasound

Researchers from Thomas Jefferson University use machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.

Machine learning improves diagnostics of head and neck cancers

Machine learning improves diagnostics of head and neck cancers

Researchers used artificial intelligence to develop a new classification method which identifies the primary origins of cancerous tissue based on chemical DNA changes.

AI classifies lung cancer slides at pathologist level

AI classifies lung cancer slides at pathologist level

Researchers have utilized machine learning capabilities to assist with the challenging task of grading tumor patterns and subtypes of lung adenocarcinoma.

AI method can detect precursors to cervical cancer

AI method can detect precursors to cervical cancer

Using AI and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.

AI can identify cancerous cells by their acidity

AI can identify cancerous cells by their acidity

Using a special dye, cells are colored according to their pH, and a machine learning algorithm can detect changes in the color spectrum due to cancer.

AI identifies precancerous colon polyps

AI identifies precancerous colon polyps

A machine learning algorithm helps accurately differentiate benign and premalignant colorectal polyps on CT colonography scans.

Chatbot ‘Gene' to help with hereditary cancer

Chatbot ‘Gene' to help with hereditary cancer

Myriad Genetics, Inc. announced a new collaboration with OptraHEALTH to implement a cognitive chatbot named Gene to provide genetic and financial assistance information to prospective patients.

Popular articles

Subscribe to Newsletter